Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02502089

Ligand	Ligand name	Chain	PDB	Tanimoto
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.79
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.78
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.78
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.78
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.78
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.78
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.76
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.76
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.76
8PG	(8S,12S)-15S-HYDROXY-9-OXOPROSTA-10Z,13E-DIEN-1-OIC ACID	A,B	2G5W	0.76
TES	TESTOSTERONE	A	1JTV	0.76
TES	TESTOSTERONE	A	2Q7L	0.76
TES	TESTOSTERONE	A	2Q7I	0.76
TES	TESTOSTERONE	A,B	1J96	0.76
TES	TESTOSTERONE	A	2Q7K	0.76
TES	TESTOSTERONE	A,B	1Q13	0.76
TES	TESTOSTERONE	H	1I9J	0.76
TES	TESTOSTERONE	A,B	1AFS	0.76
TES	TESTOSTERONE	H	1VPO	0.76
TES	TESTOSTERONE	A	2Q7J	0.76
TES	TESTOSTERONE	A,B	3BUR	0.76
TES	TESTOSTERONE	A	2AM9	0.76
1CA	DESOXYCORTICOSTERONE	A,B	1Y9R	0.75
1CA	DESOXYCORTICOSTERONE	A,B,C	2ABI	0.75
1CA	DESOXYCORTICOSTERONE	A	2Q3Y	0.75
1CA	DESOXYCORTICOSTERONE	A	2AA7	0.75
CDZ	3,5-dihydroxy-4,6,6-tris(3-methylbut-2-en-1-yl)-2-(2-methylpropanoyl)cyclohexa-2,4-dien-1-one	A	2QNV	0.75
OXR	4-OXORETINOL	A,B	1X8L	0.75
PG2	PROSTAGLANDIN D2	A,B	1RY0	0.74
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.74
20E	(2beta,3beta,5beta,22R)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one	A,D	2R40	0.73
DL7	(5beta,14beta,17alpha,25R)-3-oxocholest-7-en-26-oic acid	A	3GYU	0.73
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	A,D	1R1K	0.73
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,U	1Z5X	0.73
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,F,G,H	2NXX	0.73
LUX	(3R,3'R,6'S,9R,9'R,13R,13'S)-4',5'-DIDEHYDRO-5',6',7',8',9,9',10,10',11,11',12,12',13,13',14,14',15,15'-OCTADECAHYDRO-BETA,BETA-CAROTENE-3,3'-DIOL	A,B,C	2BHW	0.73
HCR	7-HYDROXYCHOLESTEROL	A	1ZHT	0.73
VTQ	RRR-ALPHA-TOCOPHERYLQUINONE	A,C,E	1OLM	0.72
C0R	CORTICOSTERONE	A	2A3I	0.72
C0R	CORTICOSTERONE	A,B	1Y5R	0.72
LUT	(3R,3'R,6S)-4,5-DIDEHYDRO-5,6-DIHYDRO-BETA,BETA-CAROTENE-3,3'-DIOL	A,B,C,D,E,F,G,H,I,J	1RWT	0.72
HYF	4-HYDROXY-5-ISOBUTYRYL-6-METHYL-1,3,7-TRIS-(3-METHYL-BUT-2-ENYL)-6-(4-METHYL-PENT-3-ENYL)-BICYCLO[3.3.1]NON-3-ENE-2,9-DIONE	A	1M13	0.71
JC1	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2S,3S)-3-(2-hydroxyethyl)heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol	A	2ZXN	0.71
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EAU	0.71
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB3	0.71
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB4	0.71
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	2AAX	0.71
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	1H61	0.71
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	3CMF	0.71
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	2Q1V	0.71
0MA	maslinic acid	A	2QN2	0.71
JB1	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,3S)-3-(2-hydroxyethyl)heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol	A	2ZXM	0.71
0AS	asiatic acid	A	2QN1	0.71
HEQ	3-[18-(4-HYDROXY-2,6,6-TRIMETHYL-CYCLOHEX-1-ENYL)-3,7,12,16-TETRAMETHYL-OCTADECA-1,3,5,7,9,11,13,15, 17-NONAENYL]-2,4,4-TRIMETHYL-CYCLOHEX-2-ENONE	A,B	1M98	0.71
DL4	(14beta,17alpha,25R)-3-oxocholest-4-en-26-oic acid	A	3GYT	0.71
3ON	(3R)-3-HYDROXY-8'-APOCAROTENOL	A,B,C,D	2BIW	0.71
VDY	3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL	A,B	1J78	0.7
VDY	3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL	A,D	1MZ9	0.7